Literature DB >> 15842571

Does fundoplication change the risk of esophageal cancer in the setting of GERD?

Nicholas J Shaheen.   

Abstract

The effect of a surgical antireflux procedure on the risk of cancer in those with GERD and Barrett's esophagus is unclear. Although some authorities have suggested that a surgical antireflux procedure might be superior to medical management for the prevention of cancer, the cumulative data do not demonstrate that those patients undergoing surgery have any decrement in cancer risk compared to those who receive medication. Most data available to assess the effect of surgery on cancer risk come from case series. These data are of very limited utility, because of differences in the baseline composition of groups undergoing medical and surgical therapy. Until more data are available, patients should not be advised to undergo surgical fundoplication as an antineoplastic measure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15842571     DOI: 10.1111/j.1572-0241.2005.41978.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  4 in total

1.  Invasion of a fundoplication sleeve by esophageal squamous-cell carcinoma.

Authors:  Vincent Zimmer; Jens Kraemer; Arno Buecker; Martin K Schilling; Frank Lammert; Markus Menges
Journal:  Gastrointest Cancer Res       Date:  2011-05

2.  [No cancer prevention with fundoplication : Results of a population-based study in Sweden].

Authors:  B H A von Rahden; C T Germer
Journal:  Chirurg       Date:  2011-01       Impact factor: 0.955

Review 3.  The effect of antireflux surgery on esophageal carcinogenesis in patients with barrett esophagus: a systematic review.

Authors:  Eugene Y Chang; Cynthia D Morris; Ann K Seltman; Robert W O'Rourke; Benjamin K Chan; John G Hunter; Blair A Jobe
Journal:  Ann Surg       Date:  2007-07       Impact factor: 12.969

Review 4.  Impact of changing epidemiology of gastroesophageal reflux disease on its diagnosis and treatment.

Authors:  Hugo Bonatti; Sami R Achem; Ronald A Hinder
Journal:  J Gastrointest Surg       Date:  2008-02       Impact factor: 3.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.